Artia Global Partners as of Dec. 31, 2025
Portfolio Holdings for Artia Global Partners
Artia Global Partners holds 50 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 27.2 | $192M | 1.1M | 174.04 | |
| Abivax Sa Sponsored Ads (ABVX) | 11.7 | $82M | 611k | 134.85 | |
| Argenx Se Sponsored Adr (ARGX) | 7.7 | $54M | 65k | 840.95 | |
| Eli Lilly & Co. (LLY) | 7.7 | $54M | 51k | 1074.68 | |
| Proshares Tr Ii Ultra Gold (UGL) | 4.3 | $30M | 542k | 55.52 | |
| Soleno Therapeutics (SLNO) | 3.8 | $27M | 584k | 46.30 | |
| Viking Therapeutics (VKTX) | 3.6 | $25M | 719k | 35.18 | |
| Trevi Therapeutics (TRVI) | 3.6 | $25M | 2.0M | 12.52 | |
| Uniqure Nv SHS (QURE) | 3.5 | $25M | 1.0M | 23.93 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 2.5 | $18M | 504k | 35.08 | |
| Astrazeneca Sponsored Adr | 2.5 | $18M | 191k | 91.93 | |
| Cidara Therapeutics Com New (CDTX) | 2.2 | $16M | 71k | 220.89 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 2.0 | $14M | 767k | 18.27 | |
| Ionis Pharmaceuticals (IONS) | 1.6 | $11M | 144k | 79.11 | |
| Dianthus Therapeutics (DNTH) | 1.2 | $8.5M | 205k | 41.21 | |
| Revolution Medicines (RVMD) | 1.2 | $8.3M | 104k | 79.65 | |
| Quest Diagnostics Incorporated (DGX) | 1.0 | $7.1M | 41k | 173.53 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $6.9M | 17k | 397.65 | |
| Ventyx Biosciences (VTYX) | 0.9 | $6.3M | 696k | 9.03 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.9 | $6.2M | 59k | 104.67 | |
| Mineralys Therapeutics (MLYS) | 0.7 | $5.0M | 138k | 36.29 | |
| Sionna Therapeutics (SION) | 0.7 | $4.9M | 120k | 41.14 | |
| Palisade Bio (PALI) | 0.7 | $4.7M | 2.0M | 2.35 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $4.3M | 60k | 72.13 | |
| Scholar Rock Hldg Corp (SRRK) | 0.6 | $4.2M | 96k | 44.05 | |
| Rapport Therapeutics (RAPP) | 0.6 | $4.2M | 139k | 30.34 | |
| Prokidney Corp Shs Cl A (PROK) | 0.6 | $4.1M | 1.8M | 2.24 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.5 | $3.8M | 18k | 213.24 | |
| Abbvie (ABBV) | 0.5 | $3.3M | 15k | 228.49 | |
| Belite Bio Sponsored Ads (BLTE) | 0.4 | $2.9M | 18k | 159.96 | |
| Roivant Sciences SHS (ROIV) | 0.4 | $2.8M | 130k | 21.70 | |
| Ocular Therapeutix (OCUL) | 0.4 | $2.7M | 226k | 12.14 | |
| Travere Therapeutics (TVTX) | 0.4 | $2.7M | 71k | 38.21 | |
| Bright Minds Biosciences Com New (DRUG) | 0.4 | $2.6M | 33k | 78.04 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $2.4M | 5.0k | 487.25 | |
| Protagonist Therapeutics (PTGX) | 0.3 | $2.0M | 23k | 87.34 | |
| Upstream Bio (UPB) | 0.3 | $1.9M | 69k | 27.15 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $1.8M | 40k | 44.82 | |
| Bridgebio Pharma (BBIO) | 0.2 | $1.6M | 20k | 76.49 | |
| Brightspring Health Svcs (BTSG) | 0.2 | $1.6M | 42k | 37.45 | |
| Pepgen (PEPG) | 0.2 | $1.3M | 205k | 6.51 | |
| Celcuity (CELC) | 0.2 | $1.3M | 13k | 99.74 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.2 | $1.2M | 29k | 41.25 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $815k | 8.1k | 100.59 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $755k | 42k | 18.16 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.1 | $737k | 2.5k | 294.74 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $520k | 29k | 17.80 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $513k | 42k | 12.19 | |
| Kodiak Sciences (KOD) | 0.1 | $476k | 17k | 27.96 | |
| Lyra Therapeutics Com New (LYRA) | 0.0 | $27k | 8.8k | 3.08 |
